Sinocare Challenges Abbott's Glucose Monitor Patents

By Hanna Vioque ( October 14, 2025, 3:15 PM BST) -- Chinese medical device maker Sinocare has denied Abbott's allegations that it is infringing two patents protecting technology that continuously monitors glucose levels in diabetes patients, arguing that the patents were invalid....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login